Literature DB >> 3929385

Partial inversion of the initiation-promotion sequence of multistage tumorigenesis in the skin of NMRI mice.

G Fürstenberger, V Kinzel, M Schwarz, F Marks.   

Abstract

Alterations in NMRI mouse skin induced by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate in "stage I of tumor promotion" are slowly reversible, and this reversibility has a half-time of 10 to 12 weeks. The tumor response observed in the course of an initiation-promotion experiment in vivo is independent of whether stage I of promotion occurs before or after initiation. Since the time interval between treatment with the promoter, and subsequent initiation can be extended up to at least 6 weeks, an enhancement of initiation because of promoter-induced cellular DNA synthesis seems to be unlikely. This result may be inconsistent with the two-stage model of tumor promotion because it indicates that in skin the existence of initiated cells is not required for the induction of cellular alterations that are essential for the stage of skin tumorigenesis called stage I of promotion.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3929385     DOI: 10.1126/science.3929385

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  5 in total

1.  A host-mediated in vivo/in vitro assay with peritoneal murine macrophages for the detection of carcinogenic chemicals.

Authors:  T Massa; T Gerber; V Pfaffenholz; A Chandra; B Schlatterer; P Chandra
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Superinduction of mouse epidermal ornithine decarboxylase activity by repeated 12-o-tetradecanoylphorbol-13-acetate treatments.

Authors:  A K Verma; K M Hsiao; H Ahrens; M Suganuma; H Fujiki; S Matsufuji; H Hayashi
Journal:  Mol Cell Biochem       Date:  1996-02-23       Impact factor: 3.396

3.  Early changes in the arachidonic acid metabolism of HeLa cells in response to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) and related compounds.

Authors:  U Espe; G Fürstenberger; F Marks; M Kaszkin; V Kinzel
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

4.  Inflammation, oxidative DNA damage, and carcinogenesis.

Authors:  J G Lewis; D O Adams
Journal:  Environ Health Perspect       Date:  1987-12       Impact factor: 9.031

Review 5.  Perspectives on the risk assessment for nongenotoxic carcinogens and tumor promoters.

Authors:  F P Perera
Journal:  Environ Health Perspect       Date:  1991-08       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.